Profiling psychoactive tryptamine-drug synthesis by focusing on detection using mass spectrometry

TrAC - Trends in Analytical Chemistry

Volumn 29, Issue 4, 2010, Pages 285-296

  Martins, Cláudia P B ^a   Freeman, Sally ^b   Alder, John F ^b   Passie, Torsten ^c   Brandt, Simon D ^d  

^a Thermo Fisher Scientific   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Clinical; Drug synthesis; Forensic; Fragmentation; Hallucinogen; Mass analysis; Mass spectrometry; Pharmaceutical; Soft ionization; Tryptamine

Indexed keywords

CLINICAL DRUGS; DRUG SYNTHESIS; MASS ANALYSIS; SOFT IONIZATION; TRYPTAMINES;

HALOGENATION; INTERNET; IONIZATION; MASS SPECTROMETRY; PARTICLE DETECTORS;

ELECTROSPRAY IONIZATION;

5 BROMO N,N DIMETHYLTRYPTAMINE; 5 METHOXY N METHYL N ISOPROPYLTRYPTAMINE; 5 METHOXY N METHYL N PROPYLTRYPTAMINE; 5,6 DIBROMO N,N DIMETHYLTRYPTAMINE; BUFOTENINE; INDOLE DERIVATIVE; ION; N METHYL N ETHYLTRYPTAMINE; N METHYLTRYPTAMINE; N,N DIETHYL 5 METHOXYTRYPTAMINE; N,N DIETHYLTRYPTAMINE; N,N DIISOPROPYL 5 METHOXYTRYPTAMINE; N,N DIMETHYLTRYPTAMINE; N,N TETRAMETHYLENE TRYPTAMINE; PSILOCIN; PSILOCYBINE; PSYCHOTROPIC AGENT; SEROTONIN; SOLVENT; SUMATRIPTAN; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; CHEMICAL INTERACTION; DEPRESSION; DISEASE MODEL; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSPRAY; HUMAN; INTERNET; IONIZATION; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEDATION; SEPARATION TECHNIQUE;

EID: 77950520458     PISSN: 01659936     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trac.2010.01.009     Document Type: Review

References (56)

1. Altered States of Consciousness 1969, John Wiley & Sons, Inc., New York, USA. C.T. Tart (Ed.).
2. Nichols D.E., Nichols C.D. Chem. Rev. 2008, 108:1614.
3. Callaway J.C., McKenna D.J. Neurochemistry of psychedelic drugs. Drug Abuse Handbook 1998, 485. CRC Press, Boca Raton, FL, USA. S.B. Karch (Ed.).
4. Shulgin A.T., Shulgin A. TIHKAL: The Continuation 1997, Transform Press, Berkeley, CA, USA.
5. Shulgin A.T. Basic pharmacology and effects. Hallucinogens. A Forensic Drug Handbook 2003, 67. Elsevier Science Ltd., London, UK. R.R. Laing (Ed.).
6. Gartz J. Magic Mushrooms around The World 1996, LIS Publications, Los Angeles, CA, USA.
7. J.W. Allen, J. Gartz, Teonanácatl: a bibliography of entheogenic fungi, CD-ROM, ISBN 1-5821-4399-4, 2001 (). http://www.mycoart.org.
8. Schultes R.E., Hofmann A. The Botany and Chemistry of Hallucinogens 1980, C.C. Thomas, Springfield, IL, USA.
9. Torres C.M., Repke D.B. Anadenanthera: Visionary Plant of Ancient South America 2006, The Haworth Press, Inc., Binghamton, NY, USA.
10. Nichols D.E. Pharmacol. Ther. 2004, 101:131.
11. Fantegrossi W.E., Murnane K.S., Reissig C.J. Biochem. Pharmacol. 2008, 75:17.
12. Winter J.C. Psychopharmacology 2009, 203:251.
13. Fontanilla D., Johannessen M., Hajipour A.R., Cozzi N.V., Jackson M.B., Ruoho A.E. Science (Washington, DC) 2009, 323:934.
14. Cozzi N.V., Gopalakrishnan A., Anderson L.L., Feih J.T., Shulgin A.T., Daley P.F., Ruoho A.E. J. Neural Transm. 2009, 116:1591.
15. Griffiths R.R., Richards W.A., Johnson M.W., McCann U.D., Jesse R. J. Psychopharmacol. 2008, 22:621.
16. Gouzoulis-Mayfrank E., Heekeren K., Neukirch A., Stoll M., Stock C., Obradovic M., Kovar K.A. Pharmacopsychiatry 2005, 38:301.
17. Riba J., Valle M., Urbano G., Yritia M., Morte A., Barbanoj M.J. J. Pharmacol. Exp. Ther. 2003, 306:73.
18. Grob C.S., McKenna D.J., Callaway J.C., Brito G.S., Neves E.S., Oberlaender G., Saide O.L., Labigalini E., Tacla C., Miranda C.T., Strassman R.J., Boone K.B. J. Nerv. Ment. Dis. 1996, 184:86.
19. Strassman R.J., Qualls C.R., Berg L.M. Biol. Psychiatry 1996, 39:784.
20. Vollenweider F.X., Vollenweider-Scherpenhuyzen M.F.I., Babler A., Vogel H., Hell D. Neuroreport 1998, 9:3897.
21. Kochanowska A.J., Rao K.V., Childress S., El-Alfy A., Matsumoto R.R., Kelly M., Stewart G.S., Sufka K.J., Hamann M.T. J. Nat. Prod. 2008, 71:186.
22. Tanaka E., Kamata T., Katagi M., Tsuchihashi H., Honda K. Forensic Sci. Int. 2006, 163:152.
23. Meatherall R., Sharma P. J. Anal. Toxicol. 2003, 27:313.
24. Wilson J.A., McGeorge F., Smolinske S., Meatherall R. Forensic Sci. Int. 2005, 148:31.
25. Brandt S.D., Freeman S., Fleet I.A., McGagh P., Alder J.F. Analyst (Cambridge, UK) 2005, 130:330.
26. Rodriguez-Cruz S.E. Microgram J. 2005, 3:175.
27. Brandt S.D., Freeman S., Fleet I.A., Alder J.F. Analyst (Cambridge, UK) 2005, 130:1258.
28. Rodriguez-Cruz S.E. Microgram J. 2005, 3:107.
29. McClean S., Robinson R.C., Shaw C., Smyth W.F. Rapid Commun. Mass Spectrom. 2002, 16:346.
30. Bowen R.D. Mass Spectrom. Rev. 1991, 10:225.
31. F. Troxler, Chemistry of indoles carrying basic functions, in: W.J. Houlihan (Editor), The Chemistry of Heterocyclic Compounds, Part 2, Volume 25, Indoles, Wiley-Interscience, New York, USA, 1972, p. 179.
32. Sundberg R.J. Indoles 1996, Academic Press, London, UK.
33. Freeman S., Alder J.F. Eur. J. Med. Chem. 2002, 37:527.
34. Brandt S.D., Freeman S., McGagh P., Abdul-Halim N., Alder J.F. J. Pharm. Biomed. Anal. 2004, 36:675.
35. Smith M.V. Psychedelic Chemistry 1981, Loompanics Unlimited, Port Townsend, WA, USA.
36. Snow O. LSD-25 & Tryptamine Syntheses 1998, Thoth Press, Spring Hill, FL, USA.
37. Trachsel D., Richard N. Psychedelische Chemie 2000, Nachtschatten Verlag, Solothurn, Switzerland.
38. Speeter M.E., Anthony W.C. J. Am. Chem. Soc. 1954, 76:6208.
39. Crookes D.L., Parry K.P., Smith G.F. Pol. J. Chem. 1979, 53:73.
40. Troxler F., Seemann F., Hofmann A. Helv. Chim. Acta 1959, 42:2073.
41. Gielsdorf W., Schubert K., Allin K. Arch. Kriminol. 1980, 166:21.
42. Cowie J.S., Holtham A.L., Jones L.V. J. Forensic Sci. 1982, 27:527.
43. Soine W.H. Med. Res. Rev. 1986, 6:41.
44. Stauffer R. Helv. Chim. Acta 1966, 49:1199.
45. Brandt S.D., Freeman S., Fleet I.A., McGagh P., Alder J.F. Analyst (Cambridge, UK) 2004, 129:1047.
46. Brandt S.D., Mansell D., Freeman S., Fleet I.A., Alder J.F. J. Pharm. Biomed. Anal. 2006, 41:872.
47. Martins C.P.B., Awan M.A., Freeman S., Herraiz T., Alder J.F., Brandt S.D. J. Chromatogr., A 2008, 1210:115.
48. McKenna D.J. Pharmacol. Ther. 2004, 102:111.
49. Herraiz T., Chaparro C. J. Chromatogr., A 2006, 1120:237.
50. Glennon R.A., Grella B., Tyacke R.J., Lau A., Westaway J., Hudson A.L. Bioorg. Med. Chem. Lett. 2004, 14:999.
51. E. Xenou, Synthesis of dimethyltryptamine from tryptophan, MSc Dissertation, UMIST, Manchester, UK, 2000.
52. Martins C.P.B., Freeman S., Alder J.F., Brandt S.D. J. Chromatogr., A 2009, 1216:6119.
53. N. Jensen, Tryptamines as ligands and modulators of the serotonin 5-HT2A receptor and the isolation of aeruginascin from the hallucinogenic mushroom Inocybe aeruginascens, PhD Thesis, Georg-August-Universität, Göttingen, Germany, 2004.
54. Buchanan M.S., Carroll A.R., Pass D., Quinn R.J. Magn. Reson. Chem. 2007, 45:359.
55. Brandt S.D., Martins C.P.B., Freeman S., Dempster N., Wainwright M., Riby P.G., Alder J.F. J. Pharm. Biomed. Anal. 2008, 47:207.
56. Brandt S.D., Martins C.P.B., Freeman S., Dempster N., Riby P.G., Gartz J., Alder J.F. Forensic Sci. Int. 2008, 178:162.